Results 31 to 40 of about 273,218 (326)

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management. [PDF]

open access: yes, 2017
Pancreatic cancer is one the most lethal malignancies. Only a small proportion of patients with this disease benefit from surgery. Chemotherapy provides only a transient benefit.
Michael Pimienta   +4 more
core   +2 more sources

LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer

open access: yesDiscover Oncology, 2022
Pancreatic cancer is the leading cause of cancer-related mortality because of tumor metastasis. Activation of the epithelial-to-mesenchymal transition (EMT) pathway has been confirmed to be an important driver of pancreatic cancer progression from ...
Yan Ma   +9 more
doaj   +1 more source

microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings

open access: yesJournal of Experimental & Clinical Cancer Research, 2018
Background Pancreatic cancer characterizes high recurrence and poor prognosis. In clinical practice, radiotherapy is widely used for pancreatic cancer treatment.
Chi Fang   +6 more
doaj   +1 more source

Treatment options for PNET liver metastases. a systematic review [PDF]

open access: yes, 2018
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor.
Aurello, Paolo   +8 more
core   +1 more source

Epigenetic Alterations in Pancreatic Cancer Metastasis [PDF]

open access: yesBiomolecules, 2021
Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Pancreatic ductal adenocarcinoma (PDA) is the most common (90%) and aggressive type of pancreatic cancer. Genomic analyses of PDA specimens have identified the recurrent genetic mutations that drive PDA initiation and progression.
Sarah S. Wang   +3 more
openaire   +6 more sources

A Synchronous Pancreatic Metastasis from Renal Clear Cell Carcinoma, with Unusual CT Characteristics, Completely Regressed after Therapy with Sunitinib

open access: yesCase Reports in Medicine, 2014
We present a case report of a 75-years-old woman affected by renal clear cell carcinoma with a synchronous pancreatic metastasis and a metachronous lung metastasis. This case has two peculiarities.
Salvatore Lauro   +5 more
doaj   +1 more source

Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis

open access: yesWorld Journal of Surgical Oncology, 2023
Background Liver stiffness relates to more advanced tumor status and poor outcomes in primary liver cancer, while its prognostic role in pancreatic cancer with liver metastasis is unclear.
Shu Dong   +5 more
doaj   +1 more source

Clinical implications of lymphadenectomy for invasive ductal carcinoma of the body or tail of the pancreas

open access: yesAnnals of Gastroenterological Surgery, 2022
Aim The appropriate extent of lymphadenectomy for pancreatic cancer of the body/tail has not been standardized worldwide. The present study evaluated the optimal extent of harvesting lymph nodes.
Takuya Minagawa   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy